Uric acid associates with cognition in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 14, Issue 7, 2008, Pages 576-578

  Annanmaki, Tua ^a   Pessala Driver, Anniina ^b   Hokkanen, Laura ^b   Murros, Kari ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c JORVI HOSPITAL   (Finland)

Author keywords

Cognition; Homocysteine; Parkinson's disease; Uric acid

Indexed keywords

HOMOCYSTEINE; URIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; TASK PERFORMANCE; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; WECHSLER INTELLIGENCE SCALE;

CHOICE BEHAVIOR; COGNITION DISORDERS; FEMALE; HUMANS; LINEAR MODELS; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; REACTION TIME; SPACE PERCEPTION; URIC ACID;

EID: 53749094027     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.11.001     Document Type: Article

References (14)

1. Hughes T.A., Ross H.F., Musa S., Bhattacherjee S., Nathan R.N., Mindham R.H., et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 54 8 (25 Apr 2000) 1596-1602
2. Jacobs D.M., Marder K., Cote L.J., Sano M., Stern Y., and Mayeux R. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology 45 9 (Sep 1995) 1691-1696
3. Mahieux F., Fenelon G., Flahault A., Manifacier M.J., Michelet D., and Boller F. Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 64 2 (Feb 1998) 178-183
4. Aarsland D., Andersen K., Larsen J.P., Lolk A., and Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60 3 (Mar 2003) 387-392
5. de Lau L.M., Koudstaal P.J., Hofman A., and Breteler M.M. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 58 5 (Nov 2005) 797-800
6. Annanmaki T., Muuronen A., and Murros K. Low plasma uric acid level in Parkinson's disease. Mov Disord 22 8 (15 Jun 2007) 1133-1137
7. Davies K.J., Sevanian A., Muakkassah-Kelly S.F., and Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 235 3 (1 May 1986) 747-754
8. O'Suilleabhain P.E., Sung V., Hernandez C., Lacritz L., Dewey Jr. R.B., Bottiglieri T., et al. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations. Arch Neurol 61 6 (Jun 2004) 865-868
9. Malinow M.R., Levenson J., Giral P., Nieto F.J., Razavian M., Segond P., et al. Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis 114 2 (24 Apr 1995) 175-183
10. Hong Y.S., Lee M.J., Kim K.H., Lee S.H., Lee Y.H., Kim B.G., et al. The C677 mutation in methylene tetrahydrofolate reductase gene: correlation with uric acid and cardiovascular risk factors in elderly Korean men. J Korean Med Sci 19 2 (Apr 2004) 209-213
11. Schretlen D.J., Inscore A.B., Jinnah H.A., Rao V., Gordon B., and Pearlson G.D. Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology 21 1 (Jan 2007) 136-140
12. Braak H., Rub U., Jansen Steur E.N., Del Tredici K., and de Vos R.A. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64 8 (26 Apr 2005) 1404-1410
13. Kim T.S., Pae C.U., Yoon S.J., Jang W.Y., Lee N.J., Kim J.J., et al. Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry 21 4 (Apr 2006) 344-348
14. Polidori M.C., Mattioli P., Aldred S., Cecchetti R., Stahl W., Griffiths H., et al. Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement Geriatr Cogn Disord 18 3-4 (2004) 265-270